Accessibility Menu
Moolec Science logo

Moolec Science(NASDAQ) MLEC

Current Price$7.00
Market Cap$5.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-94%
5 Year-100%
1 Year-85%
1 Month-6%
Moolec Science last closing stock price
MetricPriceDate
Last closeUSD 7.202026-07-24
Moolec Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.01%USD 6.542026-07-17
1 month-5.53%USD 7.622026-06-24
3 month-1.03%USD 7.272026-04-24
Year to date+88.4%USD 3.822025-12-31
1 year-85.45%USD 49.452025-07-24
3 year-98.54%USD 493.502023-07-25
5 year-99.51%USD 1,467.002021-07-23
Since inception-93.91%USD 117.902025-06-18

Moolec Science Financials at a Glance

Market Cap

$5.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.83M

Net Income (TTM)

-$8.28M

EPS (TTM)

$0.00

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Price

$7.00

Volume

2,313

Open

$6.88

Previous Close

$7.00

Daily Range

$6.88 - $7.00

52-Week Range

$3.08 - $54.00

Estimated Earnings Date

May 14, 2026

MLEC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moolec Science

Moolec Science S.A. is a biotechnology company focused on developing innovative ingredients for food, pet food, animal feed, and dietary supplements through molecular farming technology and precision fermentation. The company operates internationally, utilizing various plant and fungal sources to create nutritional products.

Products and Services
  • Development of meat replacements and food ingredients
  • Production of dietary supplements for human and animal consumption
  • Utilization of molecular farming technology for ingredient innovation
Growth Outlook
  • Projected increase in demand for plant-based ingredients in food markets
  • Expansion into new international markets to enhance revenue streams
  • Investment in R&D to drive product innovation and market competitiveness
Financial Highlights
  • Recent quarterly revenue of 2.64 million, showing growth potential
  • Trailing twelve months gross profit margin at 34.17%, indicating operational efficiency
  • Cash and cash equivalents of 1.93 million, providing liquidity for operations
Moolec Science S.A. is positioned in a rapidly growing sector, with increasing consumer interest in sustainable and plant-based products. The company's innovative approach to ingredient development through molecular farming technology sets it apart in the biotechnology industry. Recent financial data indicates a positive trajectory, with significant revenue growth and a solid gross profit margin, reflecting the company's operational capabilities. The focus on research and development is expected to further enhance product offerings and market reach, making Moolec Science S.A. an intriguing option for investors interested in the biotechnology and sustainable food sectors.
AI Generated • Jul 23, 2026

Industry

Food Products

Sector

Consumer Staples

Employees

103

CEO

Gastón Paladini, MBA

Website

www.moolecscience.com

Headquarters

Grand Cayman, LU KY1-9009, KY

MLEC Financials

Key Financial Metrics (TTM)

Gross Margin

34.17%

Operating Margin

-3.14%

Net Income Margin

-33.41%

Return on Equity

376.84%

Return on Capital

-5.79%

Return on Assets

-54.45%

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

726.10K

Volume

2.31K

Avg. Volume

82.93K

Financials (TTM)

Gross Profit

-$639.50K

Operating Income

-$9.14M

EBITDA

-$5.21M

Operating Cash Flow

-$5.70M

Capital Expenditure

-$419.96K

Free Cash Flow

-$6.12M

Cash & ST Invst.

$1.08M

Total Debt

$66.48M

Moolec Science Performance Analysis

Moolec Science annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20232023-06-30USD 905,049N/A
20242024-06-30USD 466,376,33051430.5%
20252025-06-30USD 333,611,248-28.5%
Moolec Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-27.8%
Q12024-09-302.2%
Q22024-12-3169.7%
Q22025-12-31N/A
Moolec Science annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.81N/A
20232023-06-30USD -225.3927725.9%
20242024-06-30USD -842.19273.7%
20252025-06-30USD -258.69-69.3%
Moolec Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-75.0%
Q12024-09-3028.6%
Q22024-12-31-20.0%
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$2.64M

+948.3%

Gross Profit

-$674.37K

-7285.5%

Gross Margin

-25.52%

N/A

Market Cap

$5.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$50.62K

N/A

Employees

103

N/A

Net Income

-$2.43M

-36.1%

EBITDA

-$1.15M

+33.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$1.08M

-74.7%

Total Debt

$66.48M

+378.6%

Accounts Receivable

$3.97M

+128.2%

Inventory

$3.99M

+930.1%

Long Term Debt

$12.03M

+10.3%

Short Term Debt

$54.45M

+1723.2%

Return on Assets

-54.45%

N/A

Return on Invested Capital

33.43%

N/A

Free Cash Flow

-$1.19M

+70.6%

Operating Cash Flow

-$890.48K

+78.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GTBPGT Biopharma, Inc.
$0.32-3.25%
GLMDGalmed Pharmaceuticals Ltd.
$0.51-7.25%
ELABPMGC Holdings Inc.
$0.90-5.15%
NCELNewcelX Ltd.
$3.76-1.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About MLEC

What is the current price of Moolec Science?

Moolec Science is trading at $7.00 per share.

What is the 52-week range for Moolec Science?

Over the past 52 weeks, Moolec Science has traded between $3.08 and $54.00.

How much debt does Moolec Science have?

As of the most recent reporting period, Moolec Science reported total debt of $22.09M.

How much cash does Moolec Science have on hand?

Moolec Science reported $1.93M in cash and cash equivalents in its most recent financial results.

What is Moolec Science’s dividend yield?

Moolec Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services